As reported by an article in La Repubblica, the publication of a report by the European Commission on the commercial practices adopted by pharmaceutical multinationals to defend their products from generic competition is imminent. According to some rumors, the report by Competition Commissioner Neelie Kroes contains harsh criticism of pharmaceutical industries which allegedly resort to illegal expedients to lengthen the life of the patents of their medicines and block the entry of generic medicines into the market. The document will be presented the day after tomorrow and seems to herald fines. Meanwhile, in recent days, officials in Brussels have carried out a series of surprise inspections at industries across half of Europe to gather new evidence.
Source: "Pharmacist33"
as
